8-10
Jul
2026
CPHI South East Asia 2026
QSNCC, Bangkok, Thailand
G49
6-8
Oct
2026
CPHI Milan 2026
Fiera Milano, Italy
8J64

Hana Pharm. Co., Ltd.

About Hana Pharm. Co., Ltd.

We develop products with the highest priority for patients and will lead the way in improving human health and quality of life.Above all, we have achieved sustained growth based on anesthetics and narcotic analgesics, in which we are recognized as the No.1 company in Korea.

Meet us at

  • CPHI South East Asia 2026

    QSNCC, Bangkok, Thailand
    08 Jul 2026 - 10 Jul 2026
  • CPHI Milan 2026

    Fiera Milano, Italy
    6 Oct 2026 - 8 Oct 2026
  • Country/Region:
    Korea, Republic Of
  • On CPHI since:
    2025
  • Employees:
    500 - 999
Company types
Pharmaceutical company
Contact info

Products from Hana Pharm. Co., Ltd. (6)

  • Dexmedetomidine HCI

    Product Dexmedetomidine HCI

    -Active Ingredients: Dexmedetomidine HCI -Dosage: 200mcg/2mL -Indication Sedation under intensive care management Conscious sedation for non-intubated patients during surgery and procedures -GMP: Korea GMP -Stability: Zone IV b
  • Isoflurane

    Product Isoflurane

    -Active Ingredients: Isoflurane -Dosage: 100mL -Indication General anesthesia -GMP: Korea GMP -Stability: Zone IV b
  • Propofol

    Product Propofol

    -Active Ingredients: Propofol -Dosage: 120mg/12mL, 200mg/20mL -Indication Induction and maintenance of general anesthesia Sedation of ventilated patients receiving intensive care Sedation of surgical and diagnostic procedures -GMP: Korea GMP -Stability: Zone IV b
  • Remimazolam

    Product Remimazolam

    -Active Ingredients: Remimzaolam Bsylate -Excipients: Dextran 40, Lactose monohydrate, sodium hydroxide, hydrochloric acid -Dosage: 20mg, 50mg -Indication: 1. Byfavo Inj. 20mg The induction and maintenance of general anesthesia The induction and maintenance of procedural sedation in adults undergoing proce...
  • Sevoflurane

    Product Sevoflurane

    -Active Ingredients: Sevoflurane -Dosage: 250mL -Indication General anesthesia -GMP: Korea GMP -Stability: Zone IV b
  • Byfavo Inj.

    Product Byfavo Inj.

    Byfavo Inj (remimazolam 20mg, 50mg) is an ultra–short–acting IV benzodiazepine sedative/anesthetic. It offers very rapid onset and offset of sedation, allowing quick patient recovery. In the body, remimazolam is rapidly metabolized by tissue esterases (not by CYP), which contributes to its brief duration a...